Alcon Ag Stock Today

ALC Stock  USD 85.57  0.07  0.08%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 3

 
High
 
Low
Very Low
Alcon AG is trading at 85.57 as of the 22nd of November 2024, a 0.08 percent increase since the beginning of the trading day. The stock's open price was 85.5. Alcon AG has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Note, on July 9, 2024, Representative Josh Gottheimer of US Congress acquired under $15k worth of Alcon AG's common stock.
Business Domain
Health Care Equipment & Services
IPO Date
9th of April 2019
Category
Healthcare
Classification
Health Care
Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland. Alcon operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. The company has 494.6 M outstanding shares of which 3.43 M shares are presently shorted by investors with about 5.85 days to cover. More on Alcon AG

Moving against Alcon Stock

  0.75CAH Cardinal HealthPairCorr
  0.69WGS GeneDx Holdings CorpPairCorr
  0.68LH LaboratoryPairCorr
  0.59VMD Viemed HealthcarePairCorr
  0.57HIMS Hims Hers Health Upward RallyPairCorr
  0.5GH Guardant HealthPairCorr

Alcon Stock Highlights

ESG Sustainability
Environmental
Governance
Social
CEODavid Endicott
Old NameAlchemia S.A.
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NYSE Composite, Swiss Leader Price, Swiss Market Index, SPASX All Technology, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.220.3409
Way Down
Slightly volatile
Gross Profit Margin0.390.5557
Way Down
Pretty Stable
Total Current Liabilities2.4 B2.5 B
Sufficiently Down
Slightly volatile
Non Current Liabilities Total4.1 B6.5 B
Way Down
Slightly volatile
Total Assets24.5 B29.6 B
Significantly Down
Slightly volatile
Total Current Assets4.3 B5.6 B
Way Down
Slightly volatile
Total Cash From Operating Activities1.3 B1.5 B
Fairly Down
Pretty Stable
Debt Levels
Alcon AG can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Alcon AG's financial leverage. It provides some insight into what part of Alcon AG's total assets is financed by creditors.
Liquidity
Alcon AG has 5.13 B in debt with debt to equity (D/E) ratio of 0.22, which may show that the company is not taking advantage of profits from borrowing. Alcon AG has a current ratio of 2.12, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for Alcon to invest in growth at high rates of return.

Change In Cash

91.68 Million
Alcon AG (ALC) is traded on New York Stock Exchange in USA. It is located in Chemin de Blandonnet 8, Geneva, Switzerland, 1214 and employs 25,000 people. Alcon AG is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a total capitalization of 42.29 B. Alcon AG runs under Health Care Equipment & Supplies sector within Health Care industry. The entity has 494.6 M outstanding shares of which 3.43 M shares are presently shorted by investors with about 5.85 days to cover. Alcon AG has about 1.03 B in cash with 1.48 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.1.
Check Alcon AG Probability Of Bankruptcy
Ownership Allocation
Alcon AG holds a total of 494.6 Million outstanding shares. Over half of Alcon AG's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that on July 9, 2024, Representative Josh Gottheimer of US Congress acquired under $15k worth of Alcon AG's common stock.
Check Alcon Ownership Details

Alcon Stock Institutional Holders

InstituionRecorded OnShares
Barclays Plc2024-06-30
6.4 M
Ako Capital Llp2024-09-30
6.2 M
Legal & General Group Plc2024-06-30
6.2 M
Select Equity Group Lp2024-09-30
5.4 M
Ubs Group Ag2024-06-30
5.1 M
Bank Of America Corp2024-06-30
4.9 M
Deutsche Bank Ag2024-06-30
4.5 M
Amundi2024-06-30
4.5 M
Brown Brothers Harriman & Co2024-09-30
M
Vanguard Group Inc2024-09-30
19.4 M
Fmr Inc2024-09-30
14.4 M
View Alcon AG Diagnostics

Alcon AG Historical Income Statement

At present, Alcon AG's Operating Income is projected to increase significantly based on the last few years of reporting. The current year's EBIT is expected to grow to about 1.2 B, whereas Total Revenue is forecasted to decline to about 7.8 B. View More Fundamentals

Alcon Stock Against Markets

Alcon AG Corporate Management

Royce BedwardGeneral VPProfile
Dieter SpaeltiIndependent DirectorProfile
Michael OnuscheckPresident - Global Businesses and InnovationProfile
Ed McGoughSenior OperationsProfile
Sergio DuplanPresident - North AmericaProfile

Already Invested in Alcon AG?

The danger of trading Alcon AG is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Alcon AG is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Alcon AG. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Alcon AG is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Alcon AG offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alcon AG's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alcon Ag Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alcon Ag Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alcon AG. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For information on how to trade Alcon Stock refer to our How to Trade Alcon Stock guide.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alcon AG. If investors know Alcon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alcon AG listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.293
Earnings Share
2.34
Revenue Per Share
19.757
Quarterly Revenue Growth
0.054
Return On Assets
0.0255
The market value of Alcon AG is measured differently than its book value, which is the value of Alcon that is recorded on the company's balance sheet. Investors also form their own opinion of Alcon AG's value that differs from its market value or its book value, called intrinsic value, which is Alcon AG's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alcon AG's market value can be influenced by many factors that don't directly affect Alcon AG's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alcon AG's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alcon AG is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alcon AG's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.